BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36156490)

  • 1. Is diabetes onset at advanced age a sign of pancreatic cancer?
    Ozsay O; Karabacak U; Cetin S; Majidova N
    Ann Ital Chir; 2022; 93():476-480. PubMed ID: 36156490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
    Lee S; Hwang HK; Kang CM; Lee WJ
    Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
    Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
    Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Pancreatic Cancer in the UK Biobank Cohort Using Polygenic Risk Scores and Diabetes Mellitus.
    Sharma S; Tapper WJ; Collins A; Hamady ZZR
    Gastroenterology; 2022 May; 162(6):1665-1674.e2. PubMed ID: 35065983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model: A Retrospective Cohort Study Using Real-World Data.
    Boursi B; Patalon T; Webb M; Margalit O; Beller T; Yang YX; Chodick G
    Pancreas; 2022 Feb; 51(2):196-199. PubMed ID: 35404897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma.
    Chang MC; Chen CH; Liang JD; Tien YW; Hsu C; Wong JM; Chang YT
    World J Gastroenterol; 2014 May; 20(17):5060-5. PubMed ID: 24803819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study.
    Ben Q; Cai Q; Li Z; Yuan Y; Ning X; Deng S; Wang K
    Eur J Cancer; 2011 Jan; 47(2):248-54. PubMed ID: 20709528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Risk of Pancreatic Cancer in Patients with a New Diagnosis of Chronic Pancreatitis.
    Munigala S; Subramaniam DS; Subramaniam DP; Burroughs TE; Conwell DL; Sheth SG
    Dig Dis Sci; 2022 Feb; 67(2):708-715. PubMed ID: 33630214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus.
    Kolb A; Rieder S; Born D; Giese NA; Giese T; Rudofsky G; Werner J; Büchler MW; Friess H; Esposito I; Kleeff J
    Cancer Biol Ther; 2009 Aug; 8(16):1527-33. PubMed ID: 19571666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES Trial): protocol of a prospective, multicentre observational trial.
    Illés D; Ivány E; Holzinger G; Kosár K; Adam MG; Kamlage B; Zsóri G; Tajti M; Svébis MM; Horváth V; Oláh I; Márta K; Váncsa S; Zádori N; Szentesi A; Czakó B; Hegyi P; Czakó L
    BMJ Open; 2020 Nov; 10(11):e037267. PubMed ID: 33444177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
    He XY; Li JF; Yao WY; Yuan YZ
    Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter study of early pancreatic cancer in Japan.
    Kanno A; Masamune A; Hanada K; Maguchi H; Shimizu Y; Ueki T; Hasebe O; Ohtsuka T; Nakamura M; Takenaka M; Kitano M; Kikuyama M; Gabata T; Yoshida K; Sasaki T; Serikawa M; Furukawa T; Yanagisawa A; Shimosegawa T;
    Pancreatology; 2018 Jan; 18(1):61-67. PubMed ID: 29170051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer-novel use of a large administrative database.
    White MJ; Sheka AC; LaRocca CJ; Irey RL; Ma S; Wirth KM; Benner A; Denbo JW; Jensen EH; Ankeny JS; Ikramuddin S; Tuttle TM; Hui JYC; Marmor S
    J Public Health (Oxf); 2023 Jun; 45(2):e266-e274. PubMed ID: 36321614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Coté GA; Xu H; Easler JJ; Imler TD; Teal E; Sherman S; Korc M
    Am J Epidemiol; 2017 Oct; 186(8):944-951. PubMed ID: 28541521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
    Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
    Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies.
    Batabyal P; Vander Hoorn S; Christophi C; Nikfarjam M
    Ann Surg Oncol; 2014 Jul; 21(7):2453-62. PubMed ID: 24609291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma.
    Gao W; Zhou Y; Li Q; Zhou Q; Tan L; Song Y; Zhao X; Yu M; Zheng S; Ye H; Zeng B; Lin Q; Zhou J; Liu Y; Huang H; Zhang H; Hu X; Li Z; Dai X; Chen R
    Diabetologia; 2015 Apr; 58(4):835-44. PubMed ID: 25636208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.
    Andersen DK; Andren-Sandberg Å; Duell EJ; Goggins M; Korc M; Petersen GM; Smith JP; Whitcomb DC
    Pancreas; 2013 Nov; 42(8):1227-37. PubMed ID: 24152948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive Models Screen New-Onset Diabetics at Low Risk of Early-Onset Pancreatic Cancer.
    Khan S; Al Heraki S; Kupec JT
    Pancreas; 2021 Oct; 50(9):1326-1330. PubMed ID: 34860819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes.
    Boursi B; Finkelman B; Giantonio BJ; Haynes K; Rustgi AK; Rhim AD; Mamtani R; Yang YX
    Gastroenterology; 2017 Mar; 152(4):840-850.e3. PubMed ID: 27923728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.